
Journal of Medicinal Chemistry p. 3684 - 3692 (1994)
Update date:2022-08-04
Topics: Synthesis Macrocyclic Design Conformational Analysis HIV-Protease Inhibitor
Podlogar
Farr
Friedrich
Tarnus
Huber
Cregge
Schirlin
Design modifications to the lead HIV-PR inhibitor 1 (MDL 73,669, K(i) = 5 nM) have been postulated based on a computational model of the 1/HIV-PR complex. A novel macrocyclic inhibitor 8 (MDL 104,168) wherein the P1 and P3 side chain
View Morewebsite:http://www.orchid-chem.com
Contact:+86-571-85395792
Address:607, North Zhongshan Road, Hangzhou 310000 China
Zhuhai Jiacheng Biological Technology Co., Ltd
Contact:0756-8800233
Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Shanghai Dianyang Industry Co.,ltd
Contact:+86 21 6492 4669
Address:Chejing RD, Songjiang District, Shanghai, China
Shanghai Kefu Chemical Co.,Ltd.
Contact:+86-21-34616196
Address:Room601-602, Xuhui Business Building, No.168, Yude Road, Shanghai
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Doi:10.1016/S0003-2670(00)87305-5
(1949)Doi:10.1007/s11243-013-9779-4
(2014)Doi:10.1016/0020-1693(94)03993-3
(1994)Doi:10.1021/jo016190t
(2002)Doi:10.1248/cpb.42.1376
(1994)Doi:10.1016/S0040-4039(00)77248-0
(1994)